COLL vs TPR · P/E 17, rev $181.9M vs P/E 46, rev $8.00B
Collegium Pharmaceutical Inc (COLL) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the COLL and TPR stock pages for the full models.
Not investment advice.